Kazachkov Y, Khaoustov V, Yoffe B, Solomon H, Klintmalm G B, Tabor E
Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, MD 20852-1448, USA.
Carcinogenesis. 1996 Oct;17(10):2207-12. doi: 10.1093/carcin/17.10.2207.
Mutations of the tumor suppressor gene p53 have been found in hepatocellular carcinomas (HCCs) from many countries where HCC is common, but p53 mutations detected by direct sequencing in HCCs from the United States (where HCC is uncommon) have been reported only rarely. p53 Exons 1 to 11 were analyzed by polymerase chain reaction, single-strand conformation polymorphism analysis, and direct sequencing in HCCs from 12 patients from the United States and in adjacent non-tumorous liver from 10 of them. Abnormalities of the p53 gene were found in five of the 12 tumors, including mutations in exon 4 (one patient), exon 5 (one patient) and exon 8 (three patients). In all 12 tumors, a normal conformation of exon 7 was found; in five of these HCCs the absence of mutations was confirmed by direct sequencing. Thus, the mutations of p53 codon 249 that have frequently been found in HCCs from endemic areas apparently do not play a role in most HCCs in the United States. Since the mutations in codon 249 are thought to be due to aflatoxin ingestion, the data suggest that factors other than aflatoxin may be responsible for the p53 abnormalities in the patients from the USA.
在许多肝癌(HCC)高发的国家,已在肝细胞癌中发现肿瘤抑制基因p53的突变,但在美国(肝癌不常见)通过直接测序检测到的p53突变却鲜有报道。采用聚合酶链反应、单链构象多态性分析及直接测序法,对来自美国的12例患者的肝癌组织以及其中10例患者的癌旁非肿瘤性肝组织进行了p53外显子1至11的分析。在12例肿瘤中有5例发现p53基因异常,包括外显子4(1例患者)、外显子5(1例患者)和外显子8(3例患者)的突变。在所有12例肿瘤中,外显子7均呈正常构象;其中5例肝癌通过直接测序证实无突变。因此,在地方性肝癌中常见的p53密码子249突变在美国大多数肝癌中显然不起作用。由于密码子249的突变被认为是由于摄入黄曲霉毒素所致,这些数据表明,除黄曲霉毒素外的其他因素可能是导致美国患者p53异常的原因。